3D Systems Corporation Stock News

A disappointing earnings report was the main news item driving down 3D Systems (DDD 2.10%) over the past few trading days, a situation compounded by a significant price target reduction from an analyst. This eroded the company's share price, which had fallen by nearly 30% week to date as of early Friday morning, according to data compiled by S&P Global Market Intelligence.

3D Systems reported weak Q1 results, due in large part to poor materials sales to dental aligner customers. Management is bearish about the impact of tariffs, and has pulled full year guidance as a result. While further cost cutting efforts will help to stem losses, I am sceptical that 3D Systems can transition to profitability in the near-term.

3D Systems (DDD -24.71%) stock fell off a cliff today, down 25.3% through 12:10 p.m. ET after missing earnings and retracting its 2025 guidance last night.

3D Systems Corporation (NYSE:DDD ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Mick McCloskey - Vice President, Treasurer and Investor Relations Jeffrey Graves - President and Chief Executive Officer Jeffrey Creech - Executive Vice President and Chief Financial Officer Conference Call Participants Troy Jensen - Cantor Fitzgerald Greg Palm - Craig-Hallum Capital...

ROCK HILL, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2025.

ROCK HILL, S.C., May 06, 2025 (GLOBE NEWSWIRE) -- 3D Systems' (NYSE: DDD) Digital Dentistry Solutions are helping dental laboratories and clinics efficiently deliver patient-specific devices to straighten, protect, repair, and replace teeth with high precision. 3D printing combined with advanced dental materials can now provide individually customized patient solutions faster, better and at a l...

ROCK HILL, S.C., April 30, 2025 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today it will release its financial results for the first quarter 2025 after the U.S. stock markets close on Monday, May 12, 2025.

The 'Undercovered' Dozen highlights 12 lesser-covered stocks, offering investment opportunities and fostering community discussion on their potential. Abeona Therapeutics is seen as a Buy due to promising FDA approvals for pz-cel and UX111, potentially transforming the company with its first commercial products by 2025. Plains GP Holdings offers stable cash flows and high dividends in the volat...